Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, International, Prospective, Randomized, Vehicle Controlled, Assessor Blinded Study Performed in Subjects With Hard to Heal Wounds, to Evaluate the Efficacy and Safety of Enzymatic Debridement With EscharEx

NCT02020746 is registered in ClinicalTrials.gov with MediWound Ltd as lead sponsor.

NCT NCT02020746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02020746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, International, Prospective, Randomized, Vehicle Controlled, Assessor Blinded Study Performed in Subjects With Hard to Heal Wounds, to Evaluate the Efficacy and Safety of Enzymatic Debridement With EscharEx
Lead sponsor
MediWound Ltd
Phase
Phase 2
Overall status
Completed
Start date
July 24, 2014
Completion date
June 4, 2018
Enrollment
111 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic lower extremity ulcers, hard to heal wounds, traumatic/ post operative wounds, venous leg ulcers